0 Комментарии
0 Поделились
4Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Global Calcium Channel Blocker Drugs Market Forecast to Reach USD 20.02 Billion by 2032, Driven by Rising Cardiovascular Disease BurdenMarket Projected to Expand at a Steady 5.87% CAGR as Combination Therapies and Extended-Release Formulations Gain Traction The global Calcium Channel Blocker (CCB) Drugs Market, underscoring its foundational role in managing chronic cardiovascular conditions. The market, valued at a substantial USD 13.65 Billion in 2023, is projected to reach USD 20.02 Billion by 2032, recording a robust...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Heart Failure Drugs Market Advances with Growing Focus on Cardiovascular HealthAccording to the latest report published by Data Bridge Market Research, the Heart Failure Drugs Market CAGR Value The large scale Heart Failure Drugs Market report comprises of historic data along with future forecast and detailed market analysis on a global, local and regional level for Heart Failure Drugs Market industry. The report helps out in mapping brand...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Heart Failure Drugs Market Driven by Growing Cardiovascular Disease Cases"Detailed Analysis of Executive Summary Heart Failure Drugs Market Size and Share An international Heart Failure Drugs Market research report is planned by gathering market research data from different corners of the globe with an experienced team of language resources. Market segmentation studies performed in this wide ranging report with respect to product type, applications, and...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Increasing Prevalence of Cardiovascular Diseases Spurs Global Fibrate Drugs MarketGlobal Demand Outlook for Executive Summary Fibrate Drugs Market Size and Share Data Bridge Market Research analyses a growth rate in the global fibrate drugs market in the forecast period 2022-2029. The expected CAGR of global fibrate drugs market is tend to be around 5.50% in the mentioned forecast period. This Fibrate Drugs Market report includes a wide-ranging evaluation of the...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Orthostatic Hypotension Drugs Market Advances with Rising Demand for Targeted Therapies and Improved Cardiovascular CareAccording to the latest report published by Data Bridge Market Research, the Orthostatic Hypotension Drugs Market Data Bridge Market Research analyses that the orthostatic hypotension drugs market, which was USD 744.93 million in 2022, is expected to reach USD 1,313.81 million by 2030, at a CAGR of 7.35% during the forecast period 2023 to 2030. Winning Orthostatic Hypotension Drugs...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Rising Prevalence of Cardiovascular Diseases Fuels Growth in the Global Heart Failure Drugs Market"Detailed Analysis of Executive Summary Heart Failure Drugs Market Size and Share Data Bridge Market Research analyses that the heart failure drugs market which was USD 8,010.62 million in 2023, would rocket up to USD 24,919.55 million by 2030, and is expected to undergo a CAGR of 15.56% during the forecast period. An international Heart Failure Drugs Market research report is...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Are Fibrate Drugs Gaining Traction in Managing Cardiovascular Risks?Fibrate Drugs Market Summary: According to the latest report published by Data Bridge Market Research, the Fibrate Drugs Market CAGR Value A large scale Fibrate Drugs Market research reports help business or organization in every sphere of trade to take better decisions, to respond the toughest business questions and reduce the risk of failure. Global market research...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Inside America’s Battle Against Cholesterol: What’s Driving the U.S. Statin MarketExecutive Summary U.S. Statin Market Size and Share Across Top Segments CAGR Value The U.S. statin market size was valued at USD 4.59 billion in 2024 and is expected to reach USD 1.57 billion by 2032, at a CAGR of 1.50% during the forecast period U.S. Statin Market is a detailed market research report that serves many purposes and gives the business a competitive advantage. To stand...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр